By Franklin ASARE-DONKOH
The Government of Ghana has launched an expansion of the national malaria vaccine immunisation programme to deliver malaria vaccines to thousands of children at high risk of malaria illness and death in Ghana.
The malaria vaccine, Mosquirix– RTS,S, the first vaccine recommended by the World Health Organisation (WHO) to prevent malaria and significantly reduce life-threatening severe malaria in children, is expected to save thousands of lives each year with this expansion programme.
Addressing the gathering at the launch in the Sunyani East Municipality in the Bono region, the Minister of Health, Mr. Kwaku Agyeman-Manu, underscored the significance of the malaria vaccine.
He explained that the expansion of the national malaria vaccine immunisation program is an intervention towards the elimination of malaria.
“Vaccination saves children’s lives; it is one of the most cost-effective public health interventions and the best way to help children survive,” Mr. Agyemang-Manu reiterated.
He therefore urged all caregivers and parents to take full advantage of the opportunity and ensure that they send their eligible children to the Child Health and Nutrition clinics, popularly known as Child Welfare Clinics or CWC, to be vaccinated against this deadly childhood disease.
Data available shows that the initial introduction of the malaria vaccine through national immunisation programmes in Ghana, Kenya, and Malawi has resulted in substantial reduction in deadly severe malaria, with a drop in child hospitalisations and a reduction in child deaths.
The WHO Representative to Ghana, Dr Francis Kasolo, maintained that the Mosquirix– RTS,S, malaria vaccine is a welcome addition to the malaria control toolbox and will offer endemic countries the opportunity to rapidly reach children in the most vulnerable places with an effective intervention through the routine immunisation platform,”
“It is critical for all stakeholders to spread the importance of the malaria vaccine and all childhood immunizations in protecting the lives and livelihoods of our children and future generations,” Dr Kasolo added.
In Ghana, the malaria vaccine implementation programme was launched in May 2019 in 42 districts across seven regions.
As at December 2022, a total of 1.4 million doses of the vaccine had been administered to eligible children, with 459,446 receiving at least one dose and 184,418 completing all four doses.
The expansion will see the delivery of malaria vaccines to children in 51 additional districts in the seven regions.
The malaria vaccine programme is being implemented in Ghana, Kenya, and Malawi, with more than 1.2 million children having received at least one dose of the malaria vaccine.
The implementation programme which comes to an end in December 2023, has provided crucial information for other malaria-endemic countries in sub-Saharan Africa to roll out the malaria vaccine in 2024.
The implementation programme is coordinated by WHO and supported by PATH, UNICEF, GlaxoSmithKline (manufacturer of the vaccine) and other stakeholders, with funding provided by Gavi, the Global Fund, and Unitaid.
